1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Bhaskaran, R.
Huang, C.C.
Chang, K.D.
Yu, C.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
269
23500
23508
8089116
Cardiotoxin II from Taiwan cobra venom, Naja naja atra. Structure in solution and comparison among homologous cardiotoxins.
1994
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
6760.242
CARDIOTOXIN II
1
man
polymer
no
no
LKCNKLVPLFYKTCPAGKNLCYKMFMVSNLTVPVKRGCIDVCPKNSALVKYVCCNTDRCN
LKCNKLVPLFYKTCPAGKNLCYKMFMVSNLTVPVKRGCIDVCPKNSALVKYVCCNTDRCN
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Chinese cobra
Naja
sample
8656
Naja atra
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1994-05-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1994-03-12
REL
12
BRUNGER
refinement
X-PLOR
LEU
1
n
1
LEU
1
A
LYS
2
n
2
LYS
2
A
CYS
3
n
3
CYS
3
A
ASN
4
n
4
ASN
4
A
LYS
5
n
5
LYS
5
A
LEU
6
n
6
LEU
6
A
VAL
7
n
7
VAL
7
A
PRO
8
n
8
PRO
8
A
LEU
9
n
9
LEU
9
A
PHE
10
n
10
PHE
10
A
TYR
11
n
11
TYR
11
A
LYS
12
n
12
LYS
12
A
THR
13
n
13
THR
13
A
CYS
14
n
14
CYS
14
A
PRO
15
n
15
PRO
15
A
ALA
16
n
16
ALA
16
A
GLY
17
n
17
GLY
17
A
LYS
18
n
18
LYS
18
A
ASN
19
n
19
ASN
19
A
LEU
20
n
20
LEU
20
A
CYS
21
n
21
CYS
21
A
TYR
22
n
22
TYR
22
A
LYS
23
n
23
LYS
23
A
MET
24
n
24
MET
24
A
PHE
25
n
25
PHE
25
A
MET
26
n
26
MET
26
A
VAL
27
n
27
VAL
27
A
SER
28
n
28
SER
28
A
ASN
29
n
29
ASN
29
A
LEU
30
n
30
LEU
30
A
THR
31
n
31
THR
31
A
VAL
32
n
32
VAL
32
A
PRO
33
n
33
PRO
33
A
VAL
34
n
34
VAL
34
A
LYS
35
n
35
LYS
35
A
ARG
36
n
36
ARG
36
A
GLY
37
n
37
GLY
37
A
CYS
38
n
38
CYS
38
A
ILE
39
n
39
ILE
39
A
ASP
40
n
40
ASP
40
A
VAL
41
n
41
VAL
41
A
CYS
42
n
42
CYS
42
A
PRO
43
n
43
PRO
43
A
LYS
44
n
44
LYS
44
A
ASN
45
n
45
ASN
45
A
SER
46
n
46
SER
46
A
ALA
47
n
47
ALA
47
A
LEU
48
n
48
LEU
48
A
VAL
49
n
49
VAL
49
A
LYS
50
n
50
LYS
50
A
TYR
51
n
51
TYR
51
A
VAL
52
n
52
VAL
52
A
CYS
53
n
53
CYS
53
A
CYS
54
n
54
CYS
54
A
ASN
55
n
55
ASN
55
A
THR
56
n
56
THR
56
A
ASP
57
n
57
ASP
57
A
ARG
58
n
58
ARG
58
A
CYS
59
n
59
CYS
59
A
ASN
60
n
60
ASN
60
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ARG
36
0.210
SIDE CHAIN
1
A
ARG
58
0.240
SIDE CHAIN
2
A
ARG
36
0.317
SIDE CHAIN
2
A
ARG
58
0.263
SIDE CHAIN
3
A
ARG
36
0.314
SIDE CHAIN
3
A
ARG
58
0.314
SIDE CHAIN
4
A
ARG
36
0.299
SIDE CHAIN
4
A
ARG
58
0.252
SIDE CHAIN
5
A
ARG
36
0.189
SIDE CHAIN
5
A
ARG
58
0.282
SIDE CHAIN
6
A
ARG
36
0.298
SIDE CHAIN
6
A
ARG
58
0.241
SIDE CHAIN
7
A
ARG
36
0.263
SIDE CHAIN
7
A
ARG
58
0.286
SIDE CHAIN
8
A
ARG
36
0.303
SIDE CHAIN
8
A
ARG
58
0.307
SIDE CHAIN
9
A
ARG
36
0.151
SIDE CHAIN
9
A
ARG
58
0.273
SIDE CHAIN
10
A
ARG
36
0.267
SIDE CHAIN
10
A
ARG
58
0.247
SIDE CHAIN
11
A
ARG
36
0.241
SIDE CHAIN
11
A
ARG
58
0.177
SIDE CHAIN
12
A
ARG
36
0.313
SIDE CHAIN
12
A
ARG
58
0.198
SIDE CHAIN
1
A
LEU
6
65.33
-93.23
1
A
VAL
7
-172.41
-59.71
1
A
PHE
10
58.81
177.15
1
A
TYR
11
-137.73
-40.44
1
A
LYS
12
93.56
-100.71
1
A
ALA
16
59.83
135.21
1
A
ASN
19
-147.85
-36.61
1
A
SER
28
-128.59
-81.24
1
A
LEU
30
-153.26
45.41
1
A
THR
31
71.07
73.25
1
A
ILE
39
-141.50
-151.06
1
A
ASP
40
-135.11
-33.09
1
A
CYS
42
-140.07
42.34
1
A
LYS
44
72.41
164.05
1
A
ASN
45
-155.49
-134.87
1
A
SER
46
-169.07
-102.25
1
A
ALA
47
-173.12
-38.88
1
A
ASN
55
-98.59
-63.59
1
A
ASP
57
65.00
120.68
1
A
CYS
59
174.83
86.74
2
A
LEU
6
61.13
166.97
2
A
PRO
8
-82.17
42.32
2
A
LEU
9
-178.24
-45.95
2
A
PHE
10
65.99
-171.60
2
A
TYR
11
-161.24
-94.12
2
A
LYS
12
162.02
-68.16
2
A
ALA
16
59.34
150.08
2
A
LYS
18
62.44
146.06
2
A
MET
24
-160.71
110.27
2
A
PHE
25
-161.06
-165.36
2
A
SER
28
-148.79
-46.09
2
A
LEU
30
-160.19
67.24
2
A
THR
31
76.10
102.78
2
A
VAL
34
-143.84
-40.71
2
A
ILE
39
-146.23
-148.41
2
A
LYS
44
64.29
149.86
2
A
SER
46
-106.92
-164.07
2
A
ASN
55
-160.26
74.45
2
A
THR
56
-160.81
78.68
2
A
ASP
57
63.40
-87.95
3
A
CYS
3
-110.80
-169.84
3
A
LEU
6
62.45
-109.45
3
A
VAL
7
-166.39
-61.53
3
A
PHE
10
64.92
-179.83
3
A
TYR
11
-137.29
-109.53
3
A
LYS
12
175.82
-145.93
3
A
ALA
16
63.54
139.66
3
A
ASN
19
-154.12
-35.28
3
A
PHE
25
-161.97
-159.86
3
A
SER
28
-172.33
-69.85
3
A
ASN
29
-88.43
-98.23
3
A
LEU
30
-119.47
65.58
3
A
THR
31
41.20
83.41
3
A
VAL
34
-121.11
-83.59
3
A
ILE
39
-160.75
-154.73
3
A
LYS
44
65.49
146.24
3
A
SER
46
-112.15
-150.46
3
A
ALA
47
-131.93
-37.86
3
A
ASN
55
-99.89
-82.18
3
A
ASP
57
78.00
-76.09
3
A
CYS
59
-162.93
114.53
4
A
LEU
6
58.18
-172.85
4
A
PHE
10
55.39
-175.87
4
A
TYR
11
-153.19
-92.70
4
A
LYS
12
157.72
-129.39
4
A
ALA
16
-110.65
-157.91
4
A
ASN
19
-132.26
-30.39
4
A
SER
28
-157.88
-80.84
4
A
ASN
29
-109.60
-83.27
4
A
THR
31
63.25
66.01
4
A
ILE
39
-138.15
-156.92
4
A
LYS
44
155.22
162.64
4
A
ASN
55
-154.80
63.18
4
A
THR
56
-148.05
35.26
4
A
ASP
57
77.42
-77.86
4
A
ARG
58
-38.36
-30.32
4
A
CYS
59
-143.93
59.09
5
A
LEU
6
52.24
-96.97
5
A
VAL
7
-153.19
-64.80
5
A
LEU
9
83.94
-43.38
5
A
PHE
10
65.78
-166.50
5
A
TYR
11
-142.11
-108.52
5
A
LYS
12
176.03
-138.04
5
A
ALA
16
168.54
128.95
5
A
LYS
18
-127.46
-138.49
5
A
ASN
19
-156.54
-52.99
5
A
LEU
20
-129.30
-169.97
5
A
ASN
29
-132.92
-45.23
5
A
LEU
30
-144.84
56.41
5
A
THR
31
43.20
84.98
5
A
VAL
34
-129.78
-61.17
5
A
CYS
42
-162.79
107.14
5
A
PRO
43
-79.60
-165.72
5
A
ASN
45
-132.16
-64.65
5
A
SER
46
80.93
-168.42
5
A
ALA
47
85.38
-59.77
5
A
LEU
48
-124.09
-50.67
5
A
ASN
55
-99.55
-81.36
5
A
ASP
57
179.72
-121.97
6
A
CYS
3
-123.12
-164.84
6
A
LEU
6
60.12
165.43
6
A
PHE
10
59.31
173.91
6
A
TYR
11
-148.17
-115.51
6
A
LYS
12
172.47
-124.08
6
A
ALA
16
59.45
150.04
6
A
ASN
19
-133.62
-48.19
6
A
SER
28
179.06
-54.11
6
A
ASN
29
-120.10
-58.02
6
A
LEU
30
-158.05
58.30
6
A
THR
31
51.61
83.16
6
A
VAL
34
-127.63
-51.38
6
A
ILE
39
-144.11
-144.01
6
A
ASP
40
-160.16
37.82
6
A
PRO
43
-76.63
-160.67
6
A
SER
46
-173.17
86.58
6
A
ALA
47
-176.55
-72.96
6
A
LEU
48
-154.38
22.08
6
A
VAL
49
-154.02
85.35
6
A
THR
56
-160.59
58.01
6
A
ASP
57
66.53
149.75
6
A
CYS
59
179.14
56.74
7
A
LEU
6
54.86
171.75
7
A
LEU
9
-132.36
-42.45
7
A
PHE
10
62.45
175.35
7
A
TYR
11
-154.01
-124.46
7
A
LYS
12
-178.29
-72.34
7
A
ALA
16
69.98
65.81
7
A
SER
28
-165.87
-80.68
7
A
ASN
29
-107.79
-91.42
7
A
LEU
30
-114.42
56.39
7
A
LYS
44
62.41
149.10
7
A
SER
46
-132.32
-154.39
7
A
THR
56
-157.06
32.85
7
A
ASP
57
76.96
-79.18
8
A
LEU
6
58.85
154.45
8
A
LEU
9
-178.02
-53.09
8
A
PHE
10
66.41
-164.40
8
A
TYR
11
-157.40
-105.20
8
A
LYS
12
-176.42
-77.53
8
A
ALA
16
167.81
-166.42
8
A
ASN
29
-121.80
-69.15
8
A
THR
31
58.07
77.26
8
A
VAL
34
-125.32
-69.90
8
A
LYS
44
66.18
167.07
8
A
SER
46
-111.25
-86.89
8
A
ALA
47
161.56
-45.14
8
A
ASN
55
-161.03
43.10
8
A
THR
56
-145.77
56.36
8
A
ASP
57
69.22
163.00
8
A
ARG
58
48.00
22.38
8
A
CYS
59
156.44
80.98
9
A
LEU
6
67.00
-103.66
9
A
VAL
7
-167.65
-60.16
9
A
LEU
9
169.40
-32.62
9
A
PHE
10
59.82
-170.36
9
A
TYR
11
-135.00
-38.56
9
A
LYS
12
103.89
-84.41
9
A
LYS
18
-135.43
-73.82
9
A
ASN
19
-160.24
-72.42
9
A
PHE
25
-161.88
-166.25
9
A
VAL
27
-46.85
166.18
9
A
SER
28
-169.01
-66.47
9
A
ASN
29
-142.49
-50.68
9
A
LEU
30
-144.39
29.55
9
A
THR
31
72.87
88.63
9
A
VAL
34
-123.96
-55.66
9
A
VAL
41
-157.43
74.38
9
A
LYS
44
67.22
125.88
9
A
ASN
45
-122.00
-144.40
9
A
SER
46
-162.74
-30.31
9
A
ALA
47
95.86
-27.15
9
A
LYS
50
-34.01
115.53
9
A
ASN
55
-153.84
54.07
9
A
THR
56
-158.24
64.03
9
A
ASP
57
54.61
165.72
9
A
ARG
58
59.53
15.29
9
A
CYS
59
159.55
68.46
10
A
LEU
6
41.92
-99.31
10
A
VAL
7
-176.17
-54.40
10
A
PHE
10
71.86
-167.66
10
A
TYR
11
-161.01
-121.91
10
A
LYS
12
178.07
-102.85
10
A
ALA
16
65.19
132.70
10
A
PHE
25
-160.71
-168.94
10
A
SER
28
-133.52
-76.25
10
A
ASN
29
-104.85
-81.43
10
A
THR
31
56.41
85.00
10
A
VAL
34
-115.98
-76.00
10
A
ILE
39
-149.10
-154.01
10
A
VAL
41
-111.37
69.80
10
A
LYS
44
73.35
117.06
10
A
SER
46
-132.08
-73.54
10
A
ALA
47
177.96
-29.09
10
A
LEU
48
-99.50
-60.68
10
A
ASN
55
-160.66
92.20
10
A
THR
56
-151.04
-50.82
10
A
ASP
57
167.95
-53.13
10
A
CYS
59
-119.87
78.68
11
A
LEU
6
176.26
-177.87
11
A
PHE
10
62.52
178.72
11
A
TYR
11
-150.48
-117.09
11
A
LYS
12
-176.52
-88.32
11
A
CYS
14
-150.55
65.86
11
A
ALA
16
77.14
89.92
11
A
PHE
25
-161.30
-169.35
11
A
SER
28
-138.37
-55.94
11
A
ASN
29
-158.50
-39.84
11
A
LEU
30
-156.69
59.12
11
A
THR
31
46.01
85.15
11
A
ILE
39
-159.04
-131.21
11
A
ASP
40
-156.96
23.14
11
A
CYS
42
-140.87
47.88
11
A
LYS
44
61.53
150.60
11
A
LEU
48
-99.31
-67.16
11
A
ASN
55
-161.25
56.33
11
A
THR
56
-161.12
69.46
11
A
ASP
57
56.17
162.67
11
A
CYS
59
169.37
53.39
12
A
CYS
3
-123.31
-167.13
12
A
LEU
6
57.06
-169.73
12
A
PHE
10
56.25
-169.72
12
A
TYR
11
-153.88
-91.89
12
A
LYS
12
160.49
-92.61
12
A
ALA
16
59.42
118.98
12
A
SER
28
-146.52
-68.32
12
A
ASN
29
-114.09
-81.78
12
A
LEU
30
-140.85
52.63
12
A
THR
31
75.98
51.58
12
A
SER
46
165.02
111.41
12
A
ALA
47
156.98
-75.23
12
A
ASN
55
-99.11
-78.80
12
A
ASP
57
66.87
138.11
12
A
CYS
59
161.77
93.71
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
CARDIOTOXIN II (NMR, 12 STRUCTURES)
CARDIOTOXIN II FROM TAIWAN COBRA VENOM, NAJA NAJA ATRA: STRUCTURE IN SOLUTION AND COMPARISION AMONG HOMOLOGOUS CARDIOTOXINS
1
Y
N
disulf
2.020
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
21
A
SG
CYS
21
1_555
disulf
2.023
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
38
A
SG
CYS
38
1_555
disulf
2.017
A
CYS
42
A
SG
CYS
42
1_555
A
CYS
53
A
SG
CYS
53
1_555
disulf
2.018
A
CYS
54
A
SG
CYS
54
1_555
A
CYS
59
A
SG
CYS
59
1_555
CARDIOTOXIN
CARDIOTOXIN
CTX2_NAJAT
UNP
1
1
P01442
MKTLLLTLVVVTIVCLDLGYTLKCNKLVPLFYKTCPAGKNLCYKMFMVSNLTVPVKRGCIDVCPKNSALVKYVCCNTDRC
N
22
81
1CRF
1
60
P01442
A
1
1
60
2
3
anti-parallel
anti-parallel
anti-parallel
A
LYS
2
A
LYS
2
A
ASN
4
A
ASN
4
A
TYR
11
A
TYR
11
A
THR
13
A
THR
13
A
LEU
20
A
LEU
20
A
PHE
25
A
PHE
25
A
LYS
35
A
LYS
35
A
ILE
39
A
ILE
39
A
LYS
50
A
LYS
50
A
CYS
54
A
CYS
54
1
P 1